- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Glucagon market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Glucagon market size is estimated to be worth US$ 572.1 million in 2021 and is forecast to a readjusted size of USD 851 million by 2028 with a CAGR of 5.8% during review period. Emergency Kits accounting for % of the Glucagon global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Inject Glucagon segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Glucagon include Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, and Taj Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Glucagon market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Inject Glucagon
Nasal Glucagon
Market segment by Application can be divided into
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
The key market players for global Glucagon market are listed below:
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glucagon product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Glucagon, with price, sales, revenue and global market share of Glucagon from 2019 to 2022.
Chapter 3, the Glucagon competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucagon breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Glucagon market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Glucagon.
Chapter 13, 14, and 15, to describe Glucagon sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Glucagon Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glucagon Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Inject Glucagon
1.2.3 Nasal Glucagon
1.3 Market Analysis by Application
1.3.1 Overview: Global Glucagon Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 Global Glucagon Market Size & Forecast
1.4.1 Global Glucagon Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Glucagon Sales in Volume (2017-2028)
1.4.3 Global Glucagon Price (2017-2028)
1.5 Global Glucagon Production Capacity Analysis
1.5.1 Global Glucagon Total Production Capacity (2017-2028)
1.5.2 Global Glucagon Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Glucagon Market Drivers
1.6.2 Glucagon Market Restraints
1.6.3 Glucagon Trends Analysis
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Glucagon Product and Services
2.1.4 Novo Nordisk Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Glucagon Product and Services
2.2.4 Eli Lilly Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Fresenius Kabi
2.3.1 Fresenius Kabi Details
2.3.2 Fresenius Kabi Major Business
2.3.3 Fresenius Kabi Glucagon Product and Services
2.3.4 Fresenius Kabi Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Torrent Labs
2.4.1 Torrent Labs Details
2.4.2 Torrent Labs Major Business
2.4.3 Torrent Labs Glucagon Product and Services
2.4.4 Torrent Labs Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Taj Pharmaceuticals
2.5.1 Taj Pharmaceuticals Details
2.5.2 Taj Pharmaceuticals Major Business
2.5.3 Taj Pharmaceuticals Glucagon Product and Services
2.5.4 Taj Pharmaceuticals Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Xeris Pharmaceuticals
2.6.1 Xeris Pharmaceuticals Details
2.6.2 Xeris Pharmaceuticals Major Business
2.6.3 Xeris Pharmaceuticals Glucagon Product and Services
2.6.4 Xeris Pharmaceuticals Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Glucagon Breakdown Data by Manufacturer
3.1 Global Glucagon Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Glucagon Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Glucagon
3.4 Market Concentration Rate
3.4.1 Top 3 Glucagon Manufacturer Market Share in 2021
3.4.2 Top 6 Glucagon Manufacturer Market Share in 2021
3.5 Global Glucagon Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Glucagon Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Glucagon Market Size by Region
4.1.1 Global Glucagon Sales in Volume by Region (2017-2028)
4.1.2 Global Glucagon Revenue by Region (2017-2028)
4.2 North America Glucagon Revenue (2017-2028)
4.3 Europe Glucagon Revenue (2017-2028)
4.4 Asia-Pacific Glucagon Revenue (2017-2028)
4.5 South America Glucagon Revenue (2017-2028)
4.6 Middle East and Africa Glucagon Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Glucagon Sales in Volume by Type (2017-2028)
5.2 Global Glucagon Revenue by Type (2017-2028)
5.3 Global Glucagon Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Glucagon Sales in Volume by Application (2017-2028)
6.2 Global Glucagon Revenue by Application (2017-2028)
6.3 Global Glucagon Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Glucagon Sales by Type (2017-2028)
7.2 North America Glucagon Sales by Application (2017-2028)
7.3 North America Glucagon Market Size by Country
7.3.1 North America Glucagon Sales in Volume by Country (2017-2028)
7.3.2 North America Glucagon Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Glucagon Sales by Type (2017-2028)
8.2 Europe Glucagon Sales by Application (2017-2028)
8.3 Europe Glucagon Market Size by Country
8.3.1 Europe Glucagon Sales in Volume by Country (2017-2028)
8.3.2 Europe Glucagon Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Glucagon Sales by Type (2017-2028)
9.2 Asia-Pacific Glucagon Sales by Application (2017-2028)
9.3 Asia-Pacific Glucagon Market Size by Region
9.3.1 Asia-Pacific Glucagon Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Glucagon Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Glucagon Sales by Type (2017-2028)
10.2 South America Glucagon Sales by Application (2017-2028)
10.3 South America Glucagon Market Size by Country
10.3.1 South America Glucagon Sales in Volume by Country (2017-2028)
10.3.2 South America Glucagon Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Glucagon Sales by Type (2017-2028)
11.2 Middle East & Africa Glucagon Sales by Application (2017-2028)
11.3 Middle East & Africa Glucagon Market Size by Country
11.3.1 Middle East & Africa Glucagon Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Glucagon Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Glucagon and Key Manufacturers
12.2 Manufacturing Costs Percentage of Glucagon
12.3 Glucagon Production Process
12.4 Glucagon Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Glucagon Typical Distributors
13.3 Glucagon Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Glucagon Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Glucagon Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk Glucagon Product and Services
Table 6. Novo Nordisk Glucagon Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly Major Business
Table 9. Eli Lilly Glucagon Product and Services
Table 10. Eli Lilly Glucagon Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 12. Fresenius Kabi Major Business
Table 13. Fresenius Kabi Glucagon Product and Services
Table 14. Fresenius Kabi Glucagon Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Torrent Labs Basic Information, Manufacturing Base and Competitors
Table 16. Torrent Labs Major Business
Table 17. Torrent Labs Glucagon Product and Services
Table 18. Torrent Labs Glucagon Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Taj Pharmaceuticals Major Business
Table 21. Taj Pharmaceuticals Glucagon Product and Services
Table 22. Taj Pharmaceuticals Glucagon Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Xeris Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Xeris Pharmaceuticals Major Business
Table 25. Xeris Pharmaceuticals Glucagon Product and Services
Table 26. Xeris Pharmaceuticals Glucagon Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Glucagon Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 28. Global Glucagon Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Glucagon, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Glucagon Production Capacity by Company, (K MT): 2020 VS 2021
Table 31. Head Office and Glucagon Production Site of Key Manufacturer
Table 32. Glucagon New Entrant and Capacity Expansion Plans
Table 33. Glucagon Mergers & Acquisitions in the Past Five Years
Table 34. Global Glucagon Sales by Region (2017-2022) & (K MT)
Table 35. Global Glucagon Sales by Region (2023-2028) & (K MT)
Table 36. Global Glucagon Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Glucagon Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Glucagon Sales by Type (2017-2022) & (K MT)
Table 39. Global Glucagon Sales by Type (2023-2028) & (K MT)
Table 40. Global Glucagon Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Glucagon Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Glucagon Price by Type (2017-2022) & (USD/MT)
Table 43. Global Glucagon Price by Type (2023-2028) & (USD/MT)
Table 44. Global Glucagon Sales by Application (2017-2022) & (K MT)
Table 45. Global Glucagon Sales by Application (2023-2028) & (K MT)
Table 46. Global Glucagon Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Glucagon Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Glucagon Price by Application (2017-2022) & (USD/MT)
Table 49. Global Glucagon Price by Application (2023-2028) & (USD/MT)
Table 50. North America Glucagon Sales by Country (2017-2022) & (K MT)
Table 51. North America Glucagon Sales by Country (2023-2028) & (K MT)
Table 52. North America Glucagon Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Glucagon Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Glucagon Sales by Type (2017-2022) & (K MT)
Table 55. North America Glucagon Sales by Type (2023-2028) & (K MT)
Table 56. North America Glucagon Sales by Application (2017-2022) & (K MT)
Table 57. North America Glucagon Sales by Application (2023-2028) & (K MT)
Table 58. Europe Glucagon Sales by Country (2017-2022) & (K MT)
Table 59. Europe Glucagon Sales by Country (2023-2028) & (K MT)
Table 60. Europe Glucagon Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Glucagon Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Glucagon Sales by Type (2017-2022) & (K MT)
Table 63. Europe Glucagon Sales by Type (2023-2028) & (K MT)
Table 64. Europe Glucagon Sales by Application (2017-2022) & (K MT)
Table 65. Europe Glucagon Sales by Application (2023-2028) & (K MT)
Table 66. Asia-Pacific Glucagon Sales by Region (2017-2022) & (K MT)
Table 67. Asia-Pacific Glucagon Sales by Region (2023-2028) & (K MT)
Table 68. Asia-Pacific Glucagon Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Glucagon Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Glucagon Sales by Type (2017-2022) & (K MT)
Table 71. Asia-Pacific Glucagon Sales by Type (2023-2028) & (K MT)
Table 72. Asia-Pacific Glucagon Sales by Application (2017-2022) & (K MT)
Table 73. Asia-Pacific Glucagon Sales by Application (2023-2028) & (K MT)
Table 74. South America Glucagon Sales by Country (2017-2022) & (K MT)
Table 75. South America Glucagon Sales by Country (2023-2028) & (K MT)
Table 76. South America Glucagon Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Glucagon Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Glucagon Sales by Type (2017-2022) & (K MT)
Table 79. South America Glucagon Sales by Type (2023-2028) & (K MT)
Table 80. South America Glucagon Sales by Application (2017-2022) & (K MT)
Table 81. South America Glucagon Sales by Application (2023-2028) & (K MT)
Table 82. Middle East & Africa Glucagon Sales by Region (2017-2022) & (K MT)
Table 83. Middle East & Africa Glucagon Sales by Region (2023-2028) & (K MT)
Table 84. Middle East & Africa Glucagon Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Glucagon Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Glucagon Sales by Type (2017-2022) & (K MT)
Table 87. Middle East & Africa Glucagon Sales by Type (2023-2028) & (K MT)
Table 88. Middle East & Africa Glucagon Sales by Application (2017-2022) & (K MT)
Table 89. Middle East & Africa Glucagon Sales by Application (2023-2028) & (K MT)
Table 90. Glucagon Raw Material
Table 91. Key Manufacturers of Glucagon Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Glucagon Typical Distributors
Table 95. Glucagon Typical Customers
List of Figures
Figure 1. Glucagon Picture
Figure 2. Global Glucagon Revenue Market Share by Type in 2021
Figure 3. Inject Glucagon
Figure 4. Nasal Glucagon
Figure 5. Global Glucagon Revenue Market Share by Application in 2021
Figure 6. Emergency Kits
Figure 7. General Use
Figure 8. Diagnostic & Motility
Figure 9. Cardiogenic Shock
Figure 10. Others
Figure 11. Global Glucagon Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 12. Global Glucagon Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Glucagon Sales (2017-2028) & (K MT)
Figure 14. Global Glucagon Price (2017-2028) & (USD/MT)
Figure 15. Global Glucagon Production Capacity (2017-2028) & (K MT)
Figure 16. Global Glucagon Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Glucagon Market Drivers
Figure 18. Glucagon Market Restraints
Figure 19. Glucagon Market Trends
Figure 20. Global Glucagon Sales Market Share by Manufacturer in 2021
Figure 21. Global Glucagon Revenue Market Share by Manufacturer in 2021
Figure 22. Glucagon Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Glucagon Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Glucagon Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Glucagon Sales Market Share by Region (2017-2028)
Figure 26. Global Glucagon Revenue Market Share by Region (2017-2028)
Figure 27. North America Glucagon Revenue (2017-2028) & (USD Million)
Figure 28. Europe Glucagon Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Glucagon Revenue (2017-2028) & (USD Million)
Figure 30. South America Glucagon Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Glucagon Revenue (2017-2028) & (USD Million)
Figure 32. Global Glucagon Sales Market Share by Type (2017-2028)
Figure 33. Global Glucagon Revenue Market Share by Type (2017-2028)
Figure 34. Global Glucagon Price by Type (2017-2028) & (USD/MT)
Figure 35. Global Glucagon Sales Market Share by Application (2017-2028)
Figure 36. Global Glucagon Revenue Market Share by Application (2017-2028)
Figure 37. Global Glucagon Price by Application (2017-2028) & (USD/MT)
Figure 38. North America Glucagon Sales Market Share by Type (2017-2028)
Figure 39. North America Glucagon Sales Market Share by Application (2017-2028)
Figure 40. North America Glucagon Sales Market Share by Country (2017-2028)
Figure 41. North America Glucagon Revenue Market Share by Country (2017-2028)
Figure 42. United States Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Glucagon Sales Market Share by Type (2017-2028)
Figure 46. Europe Glucagon Sales Market Share by Application (2017-2028)
Figure 47. Europe Glucagon Sales Market Share by Country (2017-2028)
Figure 48. Europe Glucagon Revenue Market Share by Country (2017-2028)
Figure 49. Germany Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Glucagon Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Glucagon Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Glucagon Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Glucagon Revenue Market Share by Region (2017-2028)
Figure 58. China Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Glucagon Sales Market Share by Type (2017-2028)
Figure 65. South America Glucagon Sales Market Share by Application (2017-2028)
Figure 66. South America Glucagon Sales Market Share by Country (2017-2028)
Figure 67. South America Glucagon Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Glucagon Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Glucagon Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Glucagon Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Glucagon Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Glucagon Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Glucagon in 2021
Figure 79. Manufacturing Process Analysis of Glucagon
Figure 80. Glucagon Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
